23 Ethical Marketing Zimmer Biomet is committed to marketing our products and services truthfully, responsibly and professionally. We engage in marketing activities to, among other things, announce the availability of new products and services, reinforce existing customer choices, differentiate Zimmer Biomet products and services from other products and services in the marketplace, and increase awareness of medical technologies and treatments to healthcare professionals (HCPs), patients and others. All marketing activities conducted by Zimmer Biomet must have a commercially reasonable and legitimate business purpose, and cannot involve cash, fees or other forms of compensation provided directly or indirectly to HCPs or public officials. Marketing activities are also expected to be separate from any company-sponsored training or education program. We do not use marketing to improperly influence purchasing, leasing, recommendation, use, prescription or coverage decisions associated with our products and services. Zimmer Biomet’s Statement of Engagement on Public Policy Issues We operate in a heavily regulated global marketplace and it is important to be able to express our views on a variety of proposals to policymakers and other stakeholders in a transparent manner. These efforts include monitoring public policy proposals, analyzing these proposals and advocating for those policies that enhance patient and healthcare provider access to innovative technologies to treat debilitating joint pain and musculoskeletal conditions. Zimmer Biomet is committed to participating constructively and responsibly in the public policy process. Government policy proposals to regulate the healthcare system may directly affect Zimmer Biomet’s business and the incentives for innovation. There are also important policy proposals that can further our business interests, including those of our shareholders. Zimmer Biomet actively seeks to inform the debate on these proposals in the United States and in other countries. We also support policies that advance the interests of patients, improve public health and promote access to healthcare and innovation.